Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Portola: Uncertainty on AndexXa Approval Leads to 30% Decline in Stock Price (PTLA, Buy, $31.16)

Major New Uncertainty for AndexXa

The fourth quarter conference call produced alarming information about the FDA review of AndexXa. This drug…
Read more…